Monday June 26th 2017

Posts Tagged ‘Sclerosis’

TB vaccine may reduce symptoms and brain lesions of multiple sclerosis

TB vaccine may reduce symptoms and brain lesions of <b>multiple sclerosis</b>

TB vaccine may reduce symptoms and brain lesions of multiple sclerosis THIS STUDY involved 82 adults (average age, 32) at high risk for developing multiple sclerosis because they had had an episode involving numbness, vision problems or balance problems — such an event is [Read More]

Lastest Multiple Sclerosis News

Lastest Multiple Sclerosis News

As Genzyme waits for FDA ruling, its multiple sclerosis drug wins approval in … As Cambridge biotech Genzyme awaits an upcoming US regulatory decision on its experimental multiple sclerosis drug, the medicine has won approval for sale in Canada. Genzyme said Friday [Read More]

National MS Society Partners with Accelerated Cure Project’s MS Discovery Forum to Drive Research Connections for Progressive MS

National MS Society Partners with Accelerated Cure Project’s MS Discovery Forum to Drive Research Connections for Progressive MS

The National Multiple Sclerosis Society is partnering with the Accelerated Cure Project’s (ACP) Multiple Sclerosis Discovery Forum (MSDF) – an interactive online community and information portal for researchers and clinicians – to develop resources and content [Read More]

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]